Next-Level Care: Generative AI Poised for $22B Growth in Healthcare
Resumen
The generative artificial intelligence (AI) market for healthcare is valued at more than $1 billion as of 2022, and it is projected to swell to nearly $22 billion by 2032. Technology giants, venture capitalists and private equity firms will play a significant role in that market, acting as investors, partners and innovators. Meanwhile, healthcare companies — including providers, payers, pharmaceutical companies and others — recognize generative AI’s potential to transform health and medicine and are teaming up with tech giants and startups to introduce cutting-edge AI technology to all aspects of care — from research to treatment to billing. The “Generative AI Tracker®” delves into the current state and future potential of generative AI in healthcare. It explores various use cases, examines issues and challenges, and offers examples of emerging regulations. This edition highlights select startups addressing complex healthcare challenges, including drug discovery, patient care and clinical decisions. Generative AI Companies Stand Poised to Transform the Care Continuum Healthcare-focused companies and startups are turning to generative AI innovations to tackle complex drug discovery, diagnostic testing and patient care challenges. They are securing investments, emerging from stealth mode and announcing new clients. In some instances, they are also being acquired, following a pattern commonly seen when technology becomes more established. To learn more, visit the Tracker’s Companies of Note section. Generative AI Can Improve Medical Research, Drug Development and Patient Care Large language models (LLMs), the core of generative AI, offer many applications beyond drug discovery, promising to reshape other aspects of healthcare, including provider-patient interactions and care delivery. The U.S. Department of Health and Human Services (HHS) maintains a growing list of complex and detailed AI use cases deployed or in development within the federal government. To learn more, visit the Tracker’s Innovation and Use Cases section. Generative AI’s Technology Is Not Fully Optimized for Healthcare Generative AI faces many growing pains as it seeks its footing. In a recent survey, management consulting firm Bain & Company revealed that the main barriers to generative AI in healthcare are a lack of resources, expertise and regulation, with data access and quality and organizational resistance close behind. The recurring theme across industry studies is that generative AI in healthcare is nascent and needs time to prove its efficacy and to earn public trust. To learn more, visit the Tracker’s Issues and Challenges section. About the Tracker The “Generative AI Tracker®,” a collaboration with AI-ID, delves into the current state and future potential of generative AI in healthcare. This edition examines the role that generative AI can play in transforming critical aspects of healthcare, from research to treatment.The post Next-Level Care: Generative AI Poised for $22B Growth in Healthcare first appeared on PYMNTS.com.
The post Analyzing the Effect of Approval of Ethereum ETF on Solana: Market Trends and Price Prediction appeared first on Coinpedia Fintech News The news …
Analyzing the Effect of Approval of Ethereum ETF on Solana: Market Trends and Price Prediction
Blockchain · Criptodivisas
Resumen
The post Analyzing the Effect of Approval of Ethereum ETF on Solana: Market Trends and Price Prediction appeared first on Coinpedia Fintech News The news of the approval of Ethereum ETFs by the U.S. Securities and Exchange Commission has influenced the cryptocurrency market immensely, particularly affecting Solana. Within this regulatory change, market experts indicate the rapidly changing dynamics and what it means for Solana investors. Solana’s Potential for an ETF With the approval of the Ethereum ETF by the US SEC, the question of whether Solana might also have an ETF emerges. Borovik, an observer on social platform X, indicated that the same similarities exist between Ethereum and Solana, to imply possibly a future route for the ETF of Solana. Ethereum getting a spot ETF literally means that Solana can get one also– both held an ICO– They both do the same thing– they are both used in the same wayI bet Solana gets an ETF during Trumps term— borovik (@3orovik) May 23, 2024 Anthony Scaramucci, the cofounder of SkyBridge Capital, shares a similar view that a SOL ETF will be announced in the future, citing the importance of Solana in the crypto space. Regulatory Hurdles and Market Response While some experts are optimistic about the possibility of a SOL ETF, regulatory difficulties will have to be overcome. Solana, being an altcoin, is under the radar of the SEC as it is considered an unregistered security. While the SEC has allowed Bitcoin and Ethereum to be considered commodities, Solana has no such recognition. Its recent approval of the spot ETF of Ethereum would underscore this regulatory complexity and subsequently Solana’s short-term price movement. Solana’s Price Volatility Amid Market Dynamics Following the Ethereum ETF approval, Solana has seen significant price movements. Its price dipped to a 7-day low following Ethereum’s market dominance and as the market became cautious. Observers note that there exists a connection between regulatory acceptance of Ethereum and price volatility in Solana, which indicates that major cryptocurrencies are in a correlated response to regulatory shifts. Recent staking trends have been reflective of a more cautious approach from Solana investors and node validators. As Ethereum ETFs continue to attract the attention of institutions, Solana stakeholders pulled out substantial amounts of SOL from staking contracts, possibly fearful of market uncertainties. This amount of unstaking reflects investors’ fears over the bearish impact it could have on the price trajectory of Solana. Price Forecast and Market Outlook In spite of Solana’s bounce above key support levels, sentiment in the futures markets remains bearish. Short traders dominate the scene, betting that SOL price would fail to break past key resistance levels. With significant leverage SHORT positions in play, Solana will find it hard to sustain a price uptrend in the near term. Key resistance areas and psychological support levels are telling insights into Solana’s short-term price movements amidst evolving market dynamics.
HSBC today announced the inauguration of its new U.S. headquarters at The Spiral, a renowned office building in New York City’s Hudson Yards neighborhood,…
HSBC today announced the inauguration of its new U.S. headquarters at The Spiral, a renowned office building in New York City’s Hudson Yards neighborhood, marking its largest U.S. relocation to date.
On the latest episode of Hashing It Out, Avail’s co-founder explains the need to unify multiple networks in the Web3 space, not just ideologically but thr…
Hashing It Out: Navigating the next wave of Web3 with Avail’s Anurag Arjun
Criptodivisas
Resumen
On the latest episode of Hashing It Out, Avail’s co-founder explains the need to unify multiple networks in the Web3 space, not just ideologically but through innovation.